Is It a U65 Lead or an ACA Lead? Buy the Wrong Class and You Pay for a Shopper You Can’t Close

Short answer: No — U65 and ACA leads are two different products. U65 leads are off-exchange private plans (short-term medical and fixed or hospital indemnity), bought outside the marketplace with no subsidy and no enrollment window. ACA leads are on-exchange marketplace plans, subsidy-eligible and tied to the open-enrollment calendar.

Jump to:

• Are U65 leads the same as ACA leads?
• Is this lead U65 or ACA, and how do I tell?
• When is the best time to buy each one?
• Do U65 leads have an open enrollment window?
• What do ACA and U65 leads cost?
• Will the 2026 subsidy changes shift demand to U65?

A vendor sends you a batch of “health insurance leads.” You buy them, load them into the dialer, and half the calls go nowhere. The people wanted a subsidized marketplace plan, and you sell short-term medical. Or it was the reverse.

Nobody lied to you. You just bought the wrong class of lead.

U65 and ACA are not two flavors of the same thing. They are two products. They sell in two different seasons, to two different buyers, at two different prices, and they close two different ways. Before you spend another dollar, the first question is not “how much per lead.” It is “which one is this.”

This is the decision page for that question. If you want the full off-exchange buying walkthrough, the U65 health insurance leads buyer’s guide covers it. Here we are drawing the line between the two classes and deciding which one belongs in your book.

Off-exchange or on-exchange: the split that decides the buy

Start with the one distinction everything else hangs on. It is not about age. Both markets serve people under 65. It is about where the plan lives.

ACA leads are on-exchange. The shopper is buying a marketplace plan through HealthCare.gov or a state exchange. Those plans are subsidy-eligible, so the shopper’s real question is “what does this cost me after the tax credit.”

Enrollment is gated by a calendar. Outside of open enrollment, a marketplace shopper needs a special enrollment period triggered by a qualifying life event, such as losing a job or moving, per healthinsurance.org.

U65 leads are off-exchange. The shopper is buying a private plan that never touches the marketplace: short-term medical, fixed indemnity, hospital indemnity. No subsidy applies. No calendar applies. Someone can buy one of these in March as easily as in December.

Here is the split in one view.

Conflate the two and every downstream decision goes wrong. You buy ACA leads in July, when almost nobody can enroll. You anchor your U65 campaign to the open-enrollment calendar, when U65 demand does not care about that calendar at all. The distinction is the whole game.

Is this lead U65 or ACA? Classify it before you pay

A lead does not arrive with a label you can trust. “Health insurance” on an order form tells you nothing. So run a short classification test before money changes hands.

Ask the vendor what the ad said. An ad promising “see if you qualify for a $0 plan” or “check your subsidy” is pulling marketplace shoppers. That is ACA.

An ad for “affordable coverage with no waiting for open enrollment” or “temporary health insurance” is pulling off-exchange. That is U65.

Ask what the form screened for. An ACA lead form should capture income or household size, because subsidy eligibility depends on it. A U65 form usually screens for product interest and pre-existing conditions instead, because those plans underwrite differently. If a “health insurance lead” was captured with no income question and no product context, you are buying a blind lead, and a blind lead usually turns out to be the class you cannot sell.

Ask when it was generated. A fresh lead pulled in mid-February is almost certainly off-exchange or an SEP case, because the marketplace door is closed to most shoppers by then.

The common mistake here is treating classification as the vendor’s job. It is yours. You are the one who eats the wasted dials when the class is wrong.

Two different calendars: the ACA sprint and the U65 base

ACA lead-buying is a sprint. For 2026 coverage, open enrollment on HealthCare.gov ran November 1 to January 15. Enroll by December 15 and coverage starts January 1. Enroll in the back half and it starts February 1.

Demand crests hard in that window, and vendors price to it. Fresh ACA lead prices can climb 30 to 50 percent during open enrollment, per Aged Lead Store’s 2026 pricing guide. Then the door mostly closes, and volume drops to SEP cases and aged data.

U65 lead-buying is a base load. There is no window, so demand runs steady across the year. You are not racing a deadline. You are keeping a pipeline fed.

That difference should shape how you deploy budget. If you buy ACA, you need cash and capacity staged for a ten-week rush, then a plan for the eleven quiet months. If you buy U65, you can run a consistent monthly spend and hire for steady throughput instead of a seasonal surge.

Most serious health agencies do not pick one calendar. They run U65 as the year-round base and layer the ACA sprint on top each winter. The base keeps the lights on. The sprint is the spike.

What each lead and call is worth

Price is where the two classes stop looking similar. The ranges below are typical market figures, not a single quote, but they show the shape of each buy.

ACA lead and transfer figures come from Aged Lead Store’s 2026 health insurance pricing guide, which also notes shared leads go to three to five agents each and prices live transfers with a 15 to 25 percent close rate. The U65 ranges are the typical market bands published on the Elevarus U65 and private-health lead-generation page.

Look at the call line. A U65 inbound call runs two to three times an ACA health transfer. The gap is structural, not padding. A U65 call is a year-round, higher-intent, thinner-supply unit, and the products behind it, like short-term medical and hospital indemnity, pay out on attachment and persistency rather than a single subsidized enrollment.

So do not shop on the sticker. A cheap shared ACA lead split five ways during peak week is not automatically the better buy. The unit that matters is cost per lead you can actually close, and that depends on the class, the exclusivity, and the season you buy in.

The 2026 wedge: the subsidy cliff is redrawing the ACA buy

Here is the piece most lead buyers have not priced in yet. The enhanced ACA premium tax credits, the expanded subsidies in place since 2021, are set to expire at the end of 2025 unless Congress renews them.

If they lapse, the marketplace gets more expensive fast. The average annual premium payment for subsidized enrollees would jump from about $888 to about $1,904, a 114 percent increase, per KFF. People above 400 percent of the poverty line lose subsidy eligibility outright. KFF cites a 60-year-old couple at $85,000, just above that line, whose yearly premium payment would rise by more than $22,600.

The overall premium trend points the same way. The median proposed marketplace premium increase for 2026 is 18 percent, more than double last year’s 7 percent, with insurers naming the subsidy expiration as a factor, per KFF.

For a lead buyer, this is a demand signal, not just a policy note. When on-exchange coverage prices out a slice of shoppers, some of them look for the off-exchange alternative instead. Short-term medical and indemnity plans become the fallback for people who no longer see a subsidy worth chasing. That points to steadier, possibly stronger, year-round U65 demand in 2026, on top of an ACA sprint that will be harder to close because the price after subsidy is higher.

The read is not “abandon ACA.” It is “do not bet your whole book on subsidies holding.” Keep a real U65 base so a subsidy lapse is a tailwind for you, not a hole in your pipeline.

Same junk problem, one fix: verify the lead before you are billed

Both classes share one pain, and it is the reason misclassification hurts so much. The health-lead pool is full of junk: bots, recycled data, co-registration blobs where someone checked a box for “insurance” and meant nothing by it, and chargebacks when a “lead” turns out to be nobody. Loose, lightly-regulated funnels are exactly where that junk gets dumped, and it gets dumped under the generic “health insurance leads” label that hides whether a lead is even U65 or ACA in the first place.

You cannot act on the U65-versus-ACA distinction if you cannot trust that the lead is a real person in the class it was sold as. Classification is only worth running if verification stands behind it. That is the layer Elevarus sits on:

• OTP verification confirms a real, reachable person answered before the lead or call is billed, so you are not paying for a bot or a dead number.
• Bot and spam detection strips the automated and recycled traffic out of the funnel before it reaches your dialer.
• In-market targeting matches the lead to the product and the state, so an off-exchange shopper does not land in your ACA queue and a marketplace shopper does not land in your U65 queue.

That is why verification is not a bolt-on. It is what makes the classification real. A screened, OTP-verified U65 call is worth its $120 to $200 precisely because you are not also paying for the fakes. You can see how this runs on either side of the line on the U65 private-health lead page and the ACA lead-generation page.

So which should you buy?

Work it as a decision, not a preference.

Buy ACA if you are marketplace-certified, staffed to run a hard ten-week sprint, and set up to sell on price-after-subsidy. That is a specific motion: fast, seasonal, volume-heavy, and, in 2026, running into higher post-subsidy prices you will have to close through.

Buy U65 if you sell off-exchange products, want steady year-round volume, and can work a higher-value call unit consultatively. The close is slower and more about product fit than subsidy math, and it does not stop in the spring.

For most books the honest answer is both, with the mix moving through the year. Run U65 as the base that carries the quiet months. Add the ACA sprint each winter. Then, watching the 2026 subsidy picture, be ready to shift weight toward U65 if the marketplace gets pricier and shoppers start looking off-exchange. The one bet to avoid is a book built entirely on ACA subsidies that may not be there next year.

Whichever side you buy, hold both to the same standard: a verified person, in the class you were sold, at a cost you can close against. Get the class right first. The season, the price, and the close all follow from it.

Frequently Asked Questions

Are U65 leads the same as ACA leads?

No. They are two different products. U65 leads are off-exchange private plans, such as short-term medical and fixed or hospital indemnity, bought outside the marketplace with no subsidy and no enrollment window. ACA leads are on-exchange marketplace plans, subsidy-eligible, and tied to the open-enrollment calendar. Buying one when you sell the other wastes the spend, because the shopper wants a plan you do not offer.

Is this lead U65 or ACA, and how do I tell?

Check three things before you buy. What did the ad offer: a subsidy or $0-plan angle points to ACA, while a “no waiting for open enrollment” or temporary-coverage angle points to U65. What did the form screen for: income and household size signal ACA, while product interest and health questions signal U65. And when was it generated: a fresh lead outside open enrollment is almost always off-exchange or a special-enrollment case. If a vendor cannot answer these, you are buying a blind lead.

When is the best time to buy each one?

ACA buying peaks during open enrollment, which for 2026 coverage ran November 1 to January 15. Fresh ACA lead prices rise 30 to 50 percent in that window, then volume falls to special-enrollment cases and aged data. U65 has no window, so it sells steadily all year. Most agencies run U65 as a year-round base and layer the ACA sprint on top each winter.

Do U65 leads have an open enrollment window?

No. Off-exchange private plans like short-term medical and indemnity coverage can be bought and sold year-round, with no open-enrollment gate and no special-enrollment requirement. That is a core reason U65 demand runs steady while ACA demand spikes and fades with the marketplace calendar. Do not anchor a U65 campaign to the ACA open-enrollment dates, because the two markets do not share a clock.

What do ACA and U65 leads cost?

Typical market ranges: ACA shared leads run about $10 to $30, exclusive about $30 to $80, and health live-transfers about $30 to $75, per Aged Lead Store’s 2026 guide. U65 shared leads run about $20 to $40, exclusive about $40 to $80, and inbound calls about $120 to $200, per the Elevarus U65 page. U65 calls cost more because they are year-round, higher-intent, and thinner in supply. Shop on cost per lead you can actually close, not the sticker.

Will the 2026 subsidy changes shift demand to U65?

Likely, at the margin. The enhanced ACA premium tax credits are set to expire at the end of 2025 unless renewed. If they lapse, subsidized enrollees’ average net premium more than doubles, and households over 400 percent of the poverty line lose the credit entirely, per KFF. Some priced-out shoppers look off-exchange instead, which points to steadier or stronger year-round U65 demand. Keep a U65 base so a subsidy lapse is a tailwind, not a gap in your pipeline.